Click to open contact form.
Your Global Partners in the Business of Innovation

Pfizer Buys Rights to BioRap Autoimmune Drug

Publications / May 31, 2016

Senior Partner Yael Baratz represented BioRap Technologies Ltd., the technology transfer company of the Rappaport Institute for Biomedical Research at the Technion, in the drafting and negotiation of a research collaboration, option and license agreement with Pfizer Inc. Senior Partner Mark Cohen and Partner Irit Gordon handled the IP matters vis-à-vis Pfizer. The agreement aims to further develop a certain monoclonal antibody into potential new treatment options for a number of chronic autoimmune diseases such as Inflammatory Bowel Disease, Diabetes and Multiple Sclerosis.

CLICK HERE for the full article.

INNOVATION HIGHLIGHTS